TaiMed Biologics Inc., a biotechnology company, develops medicines for the prevention and treatment of viral infectious diseases in Taiwan. The company’s drug candidate products comprise TMB-355, a humanized monoclonal antibody for the treatment of HIV/AIDS; TMB-607, a novel HIV-1 protease inhibitor; and TMB-571, a small molecule inhibitor of influenza virus neuraminidase. It is also involved in the development of 2nd generation TMB-355 and a HIV integrase inhibitor program. The company was founded in 2007 and is based in Taipei City, Taiwan.
taimed biologics inc (4147:Taiwan)
No.607, Ruiguang Road
Taipei City, 11503
Phone: 886 2 2658 0058
Fax: 886 2 2658 6058www.tmb.com.tw
|No competitor information is available for 4147.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact TAIMED BIOLOGICS INC, please visit www.tmb.com.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.